Durable response for ampullary and duodenal adenocarcinoma with a nab‐paclitaxel plus gemcitabine ± cisplatin combination

BACKGROUND/AIM: There is no standard salvage chemotherapy for metastatic periampullary adenocarcinoma and duodenal adenocarcinoma and the prognosis of those who fail oxaliplatin, irinotecan, and 5FU is dismal. We examined nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel) as salvage therapy for...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Med
Main Authors: Cen, Putao, Wray, Curtis J., Zhang, Songlin, Thosani, Nirav C., Dinh, Brian Cuong, Gonzalez, Anneliese, Mohlere, Virginia, Bynon, John Steven
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Clinical Cancer Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6601707/
https://ncbi.nlm.nih.gov/pubmed/31102323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2181
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker